Orexigen Therapeutics

Orexigen’s commitment to patients is reflected in all that we do: we are a company driven by the knowledge that our work is important and the desire to make a difference.

Orexigen offers prospective employees exciting challenges, unique opportunities for career growth, and a fast-paced environment that emphasizes innovation and achievement.

San Diego, US
67 (est)+43%
Orexigen Therapeutics was founded in 2002 and is headquartered in San Diego, US

Orexigen Therapeutics Locations

San Diego, US

Orexigen Therapeutics Metrics

Orexigen Therapeutics Summary

Market capitalization

$46.8 M

Closing share price

Orexigen Therapeutics's current market capitalization is $46.8 M.

Orexigen Therapeutics Financials

Orexigen Therapeutics's revenue is $24.5 M in FY, 2015 which is 55.95% decrease from the previous period.
FY, 2013FY, 2014FY, 2015


$3.43 M$55.5 M$24.5 M

Operating income

$-77.2 M$-30.5 M$-60.1 M

Operating expense total

$80.6 M$86.1 M$84.5 M

Net Income

$-77.7 M$-37.5 M$-68.7 M

Operating cash flow

$19.8 M$6.12 M$51.2 M

    Orexigen Therapeutics Market Value History

    We estimate that Orexigen Therapeutics's current employees are approximately 20% female and 80% male.

    Orexigen Therapeutics News

    Orexigen Therapeutics Company Life

    You may also be interested in